|
Prioritising research funding focuses research efforts
on the root causes of CFS and avoids wasting money on researching
secondary symptoms and "pet projects" which have little or no
value. Prioritising research funding imposes discipline, integrity and
structure on the research process, and this can save valuable time, money and
resources, and achieve faster and better results which will lead to a diagnostic tool for CFS
and successful treatments.
We need more national government funding for research which investigates the root causes of CFS and how
they are related to the various abnormalities and dysfunctions found in
CFS. The following research areas are in order of importance and
funding priority:
-
Genetic
factors in CFS.
Chart the changes in gene expression in CFS. In 2005, scientific
researchers found abnormalities in 16 genes (Journal
of Clinical Pathology, 2005 ; 58: 826-832). The following genes
were abnormally expressed
ABCD4, PRKCL1, MRPL23, CD2BP2, GSN, NTE,
POLR2G, PEX16, EIF2B4, EIF4G1, ANAPC11, PDCD2, KHSRP, BRMS1, and
GABARAPL1, IL-10RA.
Click
here for full research paper.
Further research and studies will reveal other gene
abnormalities in CFS. The following areas would be vitally important :
|
-
|
The
genetic reasons for the RnaseL abnormality and accompanying STAT1-alpha
and p53 deficiencies and
how all of this contributes to immune system dysfunction and
other abnormalities found in CFS.
|
|
-
|
Genetic
reasons for increased neutrophil apoptosis,
over-activation of the TH2 cytokines, and under-activation of
TH1 cytokines, altered interferon production, low NK cell
numbers and activity, weakened cell mediated immunity.
|
| - |
Genetic
reasons for the mitochondria dysfunction found in CFS |
|
-
|
The
genetic effects of infection by specific viruses and / or
mycoplasmas and exposure to certain toxins
and heavy metals found in CFS patients
|
Can
these processes be blocked and / or can the pathways be restored to
normal by gene based therapies ? ;
-
RnaseL
abnormality
The reasons for the following:
(i) the cleavage
of the 80 kDa form of RnaseL into 37 kDa RnaseL. The accompanying high
LMW RnaseL (37 kDa)
to HMW RnaseL (80
kDa) ratios found in CFS patients
(ii) the cleavage
of STAT1-alpha protein, and accompanying STAT1-alpha deficiencies
(iii) the cleavage
of p53 protein, and accompanying p53 deficiencies
(iv) the abnormal caspase activity and disrupted cell
apoptic process
(v) The cleavage
of RnaseL leads to the presence of RnaseL
fragments. 3 RnaseL fragments have been found to be significant:
Fragment 1, an ankyrin binding repeat domain which is known to
interact with various transport proteins. It is is capable of NF-kappaB
mimicry ;
Fragment 2, the 2-5A binding fragment that has catalytic
activity and thus is able to degrade RNA ;
Fragment 3, shares homology with chain A of Cdk6 (Cyclin dependent
kinase). It of Cdk6 chain A mimicry ;
Research article:
Total
Exposure: Expanded Model for RNase L Fragmentation in CFS Uncovered;
The National CFIDS Foundation Announces the Use of Elastase Inhibitors
as a Potential Treatment for CFS Patients (2003)
(vi) Cell Apoptosis (cell death) increases initially in CFS and
then is inhibited when the levels of Rnase L related fragments reach a
certain point
(vii) cleavage of Actin ;
All of the above factors (i) to (vii) above interfere
with the 2-5A synthetase / RNaseL pathway which is part of the
anti-viral and anti-mycoplasma defense mechanism in cells. RnaseL
destroys both viral messenger RNA and human messenger RNA. An
over-active RnaseL destroys human messenger RNA preventing synthesis
of essential human proteins and putting cells into significant
dysfunction. Research by Suhadolnik, De Meirleir and De Becker
show that the abnormal RnaseL
in CFS is over ten times as destructive as normal Rnase L, and this
destructive phase continues indefinitely for years.
What is causing all of these abnormalities and how is it doing it ?
The chief suspects are:
- human luekocyte elastase (tests carried out by Dr. Kenny De Meirleir
seem to confirm that elastase is the main culprit)
- calpain
- protease
- other proteolytic enzymes
- ATP deficiency and abnormal mitochondria degeneration and
destruction
- environmental chemicals and toxins
- mercury poisoning
- other heavy metals
- ciguatera poisoning
- prolonged and excessive release of stress hormones. Part
played by Adrenal gland burn-out, HPA axis dysfunction.
- specific viruses: HHV6a virus, EBV, CMV,
Stealth virus (from a subclass of retroviruses called "spumaviruses"),
JHK virus, Parvovirus B-19, Enteroviruses mainly Cocksackie B in
spinal fluids, blood, brain, nerve tissue and muscle tissues:
- specific mycoplasmas: M. fermentans, M. penumoniae, M.
hominis, M. penetrans, M. pirum, M. incognito.
- chlamydia: chlamydia pneumonia
- does one of the above infections initiate an immune response which
somehow leads to the cleavage
of the 80 kDa form of RnaseL into 37 kDa RnaseL, the cleavage
of STAT1-alpha protein, etc. and the beginning of CFS.
Each of the above factors must be analysed in some depth in order to
determine their part in the
cleavage of the 80 kDa form of RnaseL and the cleavage of
STAT1-alpha protein, the abnormal caspase activity, the STAT1-alpha
and p53 deficiencies, etc.
Can this
process be blocked and / or can the pathways be restored to normal ?
Why is the drug Ampligen effective in many cases, and why is long-term
treatment necessary ?
-
Effects
of Rnase L (37 kDa
RnaseL) :
RnaseL destroys both viral messenger RNA and human messenger
RNA. An
over-active RnaseL destroys human messenger RNA preventing protein
synthesis within cells and putting cells into significant dysfunction.
Research by Suhadolnik, De Meirleir and De Becker
show that the abnormal Rnase L
(37 kDa RnaseL) in
CFS is over ten times as destructive as normal Rnase L, and this
destructive phase continues indefinitely for years.
What are the full effects of LMW RnaseL (37
kDa RnaseL) and RnaseL fragments on:
- human messenger RNA
- protein synthesis within cells and other cell functions
- mitochondria function & ATP production. Does it contribute to
the abnormally high build-up of lactic acid in the cells of CFS
patients ?
- the liver
- the immune system
- the kidneys
- growth hormone production
- HPA glands
- muscles
- brain and nervous system
How is the RnaseL abnormality
and accompanying STAT1-alpha
and p53 deficiencies related
to other immune system dysfunctions such as
- suppression of TH1 cytokines and over-activation of TH2
cytokines
- increased neutrophil apoptosis
- altered interferon production
- low natural killer cell numbers and activity levels
- weakened cell mediated immunity ?
Can this process
be blocked and / or can the pathways be restored to normal ? ;
According
to Dr. Paul Cheney (who has successfully treated hundreds of CFS
patients) the above effects form Phase I of CFS ; this can last
from a few months to a few years.
Can this process
be blocked and / or can the pathways be restored to normal ? ;
-
Elastase
is involved in CFS, it can inflict the following :
|
-
|
cleaves insulin-like
growth factors and their binding proteins. It induces a
significant proteolytic cleavage of IGFBP-3 ? Why is the
IGFBP-3 / IGF-1 ratio greater than 3.5 in many CFS
patients ? Why is this leading to low growth hormone levels ?
|
|
-
|
the
cleavage
of the 80 kDa form of RnaseL into 37 kDa RnaseL (tests
carried out by Dr. Kenny De Meirleir seem to confirm this)
|
|
-
|
cleaves T4-binding
globulin, adversely affecting thyroid hormones
|
|
-
|
cleaves
corticosteroid binding globulins, adversely affecting
corticosteroids and adrenal hormones
|
|
-
|
elastase
regulates Stromal cell-derived factor-1 (SDF-1) / CXCR4
binding. This is very significant because Human Herpes Virus-6
(HHV-6) uses the CXCR4 receptor for infection. HHV-6 virus
infection has been found in a majority of CFS patients
|
|
-
|
cleavage
of Actin. This has also been found in Behcet's disease.
|
|
-
|
Elastase
is also involved in chronic inflammation, and several
inflammatory diseases
|
Most
of the above factors are involved in CFS. What are the full effects of
elastase in CFS - immune system effects, hormone effects,
HPA axis effects, neurological effects, liver effects, mitochondria
effects ? Can it explain the wide variety of dysfunctions and
abnormalities found in CFS ?
What starts or brings about this destructive elastase activity ?
Can this elastase
activity be blocked and / or can the pathways be restored to normal ?
;
-
According
to Dr. Paul Cheney (who has successfully treated hundreds of CFS
patients) LMW RnaseL by destroying messenger RNA and blocking protein
synthesis disrupts the production of liver enzymes and leads to
impaired Liver detoxification. This leads on to a build-up of toxicity
in the body which forms Phase II of CFS. This increased
level of toxicity damages the brain and several organs and glands,
worsening the effects of CFS. This can last from two years to ten
years or more.
| - |
What
are the full effects of LMW RnaseL (
37 kDa RnaseL) and RnaseL fragments on liver
functions and detoxification in CFS patients ? |
| - |
Do
CFS patients have impaired Liver detoxification and a build-up
of toxicity in the body and if so, what is causing it ? Is
this related to the depletion / deficiency of growth hormone
and Glutathione found in most CFS patients ? |
| - |
Why
is there a urinary marker called CFSUM 1 in CFS and how is it
related to intestinal infection and toxicity ? |
Can
these processes be blocked and / or can the pathways be restored to
normal ? ;
-
According
to Dr. Paul Cheney (who has successfully treated hundreds of CFS
patients) the build-up of toxicity in the body becomes cumulative over
time, damaging the brain, mainly
the subcortex in the
brain, the
hypothalamus, the pituitary gland and adrenal gland, the immune
system, muscles, cell functions, mitochondria & ATP production,
and nervous system. This ongoing damage has a particularly devastating
effect on CFS patients, causing severe fatigue. Thus patients remain
in a state of sickness over many years. This forms Phase III of
CFS ; this can last from three to twenty years or more. This
toxicity leaves people highly susceptible to premature deaths from
cancers, opportunistic infections and heart attacks.
What are the full effects of this toxic build-up on the following :
| - |
Hypothalamus,
the pituitary gland and adrenal gland. Identify structural and
functional defects, and hormonal deficiencies. Concentrate
firstly on the lack of growth hormone, cortisol and
anti-diuretic hormone,
which are the main hormonal deficiencies found in CFS
patients. |
| - |
Subcortex
in the brain |
| - |
Mitochondria
& ATP production. Including the abnormally high build-up
of lactic acid in the cells of CFS patients. |
| - |
Glutathione
levels in the body |
| - |
Immune
system function |
Does
this build-up of toxicity play a part in the progression and worsening
of CFS ?
Can this process
be blocked and / or can the pathways be restored to normal ? ;
-
Mitochondria
:
Scientists have consistently found abnormal mitochondria degeneration
and destruction in CFS patients (see
Scientific Evidence section ). What is causing this ?
Why is there defective mitochondria function in CFS
patients ? Why are the mitochondria not completing the aerobic
processes that metabolise glucose, to form complete oxidation ?
Why is there an abnormally
high build-up of lactic acid in the cells of CFS patients ?
Scientists already know that if mitochondria can't function properly,
pyruvate is converted to lactate acid and other organic acids.
Does this explain the intracellular
acidosis and extracellular alkalosis found in CFS ?
What exactly is causing this mitochondria dysfunction ?
- LMW RnaseL (37
kDa RnaseL)
- STAT1-alpha and p53 deficiencies
- Lack of human messenger RNA
- Lack of protein synthesis
- Deficiency of SOD and / or Glutathione. This would force the
body to cut back on or shut down the aerobic energy conversion
process.
- Glutathione reduction induces an increase in citrate levels,
which can inhibit 2,3 DPG. Citrate is a very potent inhibitor of 2,3
DPG in the red cells. A deficiency of 2,3 DPG leads to a reduction of
oxygen to the mitochondria.
- Alkaline blood (Alkaline blood inhibits oxygen transport to
the mitochondria)
- Mercury poisoning. Mercury can interfere with and block
Glutathione.
- The build-up of toxins and heavy metals within the body
- Viral and / or mycoplasma infection
- DNA Gene Re-arrangement or Alterations in Normal Expression
- Growth Hormone Deficiency
Can this process be blocked and / or can the pathways be restored to
normal ? ;
-
Why
is there Chronic Ciguatera poisoning in a majority of CFS patients ? ;
Can this disease
process be blocked and / or can the pathways be restored to normal ?
;
-
Brain
:
- Reasons for brain hypo-perfusion and lesions
- Reasons for dysfunction of the subcortex
- Reasons for cortisol and serotonin abnormalities
- Why is there excess NMDA activity in the brain and a deficiency of
GABA activity ?
Can
this disease process be blocked and / or can the pathways be restored
to normal ? ;
-
The
full effects of the following infections in the spinal fluids, blood,
brain, nerve tissue and muscle tissues of CFS patients:
specific viruses: HHV6a virus, EBV, CMV, Stealth virus (from a
subclass of retroviruses called "spumaviruses"), JHK virus,
Parvovirus B-19, Enteroviruses mainly Cocksackie B.
specific mycoplasmas: M. fermentans, M. penumoniae, M. hominis,
M. penetrans, M. pirum, M. incognito.
chlamydia: chlamydia pneumonia
-
Are
the crimson crescents in the mouth related to an ongoing viral
infection ? Is it a form of Kasposi's Sarcoma ?
-
Why
is there a unique urinary marker called N-methylpyrrolidine found in a
significant number of CFS patients ? This is associated with
amyloid formation and protein misfolding, is this part of CFS ? The
expression of the Huntington's protein in CFS patients, using
gene expression analysis at the CDC points towards amyloid formation
and a neuro-degenerative process in CFS.
Is this related to the RnaseL abnormality, STAT1-alpha and p53
deficiency or to elastase activity or to Chronic Ciguatera poisoning ?
Can this disease
process be blocked and / or can the pathways be restored to normal ?
-
The
interactions between all of the above abnormalities ;
If
there is a lack of CFS researchers or technological resources within a
country then the national government should sub-contract out research to
top researchers in other countries who will be able to carry out the
research work and deliver the results.
|